For: | Du QH, Zhang CJ, Li WH, Mu Y, Xu Y, Lowe S, Han L, Yu X, Wang SY, Li Y, Li J. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation. World J Gastroenterol 2020; 26(21): 2810-2820 [PMID: 32550756 DOI: 10.3748/wjg.v26.i21.2810] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i21/2810.htm |
Number | Citing Articles |
1 |
Ying Fang, Ye Liu, Dingchun Li, Yi Miu, Kexuan Chen, Jv Zhou, Lijuan Xie, Xinting Chen, Jingyan Wu, Ying Zhu, Lechun Lv, Wu Li. Role of integrin α4 in the inhibition of fibrosis in activated hepatic stellate cells by Periplaneta americana extract. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1517491
|
2 |
Na Jiang, Jing Zhang, Jian Ping, Lieming Xu. Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.938856
|
3 |
Liu Shi, Li Zhou, Ming Han, Yu Zhang, Yang Zhang, Xiao-Xue Yuan, Hong-Ping Lu, Yun Wang, Xue-Liang Yang, Chen Liu, Jun Wang, Pu Liang, Shun-Ai Liu, Xiao-Jing Liu, Jun Cheng, Shu-Mei Lin. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways. World Journal of Gastroenterology 2023; 29(18): 2798-2817 doi: 10.3748/wjg.v29.i18.2798
|
4 |
Chan Mo, Shuwen Xie, Ting Zeng, Yuqi Lai, Sha Huang, Chuying Zhou, Weixin Yan, Shaohui Huang, Lei Gao, Zhiping Lv. Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation. Phytomedicine 2021; 84: 153524 doi: 10.1016/j.phymed.2021.153524
|
5 |
Sathish Kumar Mungamuri, Nabanita Chatterjee, Dilkash Ara. Phytotherapy for Liver Fibrosis: Insights From the Biology of Hepatic Stellate Cells—A Narrative Review. Liver International Communications 2025; 6(1) doi: 10.1002/lci2.70015
|
6 |
Shihao Zheng, Chengyuan Xue, Size Li, Wenying Qi, Xiaobin Zao, Xiaoke Li, Wei Wang, Qiyao Liu, Xu Cao, Peng Zhang, Yongan Ye. Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways. The American Journal of Chinese Medicine 2024; 52(06): 1693 doi: 10.1142/S0192415X24500666
|
7 |
Wen Gao, Yichang Zhao, Lin Guo, Yikun Wang, Hui Gong, Bikui Zhang, Miao Yan. Comparative effectiveness of glycyrrhizic acid preparations aimed at improving liver function of patients with chronic hepatitis B: A network meta-analysis of 53 randomized controlled trials. Phytomedicine 2023; 116: 154883 doi: 10.1016/j.phymed.2023.154883
|
8 |
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
|
9 |
Mingyu Wu, Ke Li, Jiabin Wu, Xianyi Ding, Xiaotong Ma, Wenhong Wang, Weihua Xiao. Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases. Pharmacological Research 2025; 212: 107571 doi: 10.1016/j.phrs.2024.107571
|
10 |
Xin Zhao, Lingyu Li, Shuang Li, Jinyu Liu, Hongya Wang, Yulin Lin, Dayong Cai. Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3. European Journal of Pharmacology 2022; 929: 175115 doi: 10.1016/j.ejphar.2022.175115
|
11 |
Xiaomei Zhong, Yibin Sun, Yanxiang Lin, Shan Deng, Huan Wang, Xian Zhou, Jinjian Lu, Yanfang Zheng, Ruoyin Luo, Mingqing Huang, Jianyuan Song. Ginsenoside Rd protects against acute liver injury by regulating the autophagy NLRP3 inflammasome pathway. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87991-9
|